Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Queensland Health
Cantor Fitzgerald
Cipla
Johnson and Johnson
Fish and Richardson
Chinese Patent Office
AstraZeneca
Accenture

Generated: December 17, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PENNSAID

« Back to Dashboard

Clinical Trials for Pennsaid

Trial ID Title Status Sponsor Phase Summary
NCT01119898 Evaluation of the Safety and Efficacy of PENNSAID Gel in the Treatment of Osteoarthritis of the Knee Completed Mallinckrodt Phase 2 Osteoarthritis (OA) is the most common form of arthritis and can cause pain, swelling, and reduced motion in the joints, which as a result can impact quality of life. It can occur in any joint, but usually affects the hands, knees, hips or spine. The purpose of this study is to determine the efficacy and safety of a topical nonsteroidal anti-inflammatory drug (NSAID) gel formulation in the treatment of osteoarthritis of the knee.
NCT01202799 Pharmacokinetics, Bioavailability and Safety of PENNSAID® Gel Completed Mallinckrodt Phase 1 It is anticipated that PENNSAID Gel will minimize systemic exposure versus oral diclofenac administered twice a day (BID). In addition, PENNSAID Gel should result in greater subject convenience and compliance with a comparable bioavailability, safety and tolerability profile to that of the approved PENNSAID solution administered four times a day (QID).
NCT01350622 Efficacy of PENNSAID® for Pain Management in the Emergency Department Withdrawn Medtronic - MITG N/A The primary objective of this study is to compare the pain relieving effect and speed of onset of PENNSAID to that of standard oral diclofenac under double blind conditions using a growth curve approach to pain measurement. The investigators will test the hypothesis that PENNSAID will provide more rapid pain relief than oral diclofenac during the ED visit. The secondary goal of the proposed work is to discover and model the onset and course of pain relief during the emergency department (ED) visit.
NCT01350622 Efficacy of PENNSAID® for Pain Management in the Emergency Department Withdrawn Virgil Davis N/A The primary objective of this study is to compare the pain relieving effect and speed of onset of PENNSAID to that of standard oral diclofenac under double blind conditions using a growth curve approach to pain measurement. The investigators will test the hypothesis that PENNSAID will provide more rapid pain relief than oral diclofenac during the ED visit. The secondary goal of the proposed work is to discover and model the onset and course of pain relief during the emergency department (ED) visit.
NCT01508676 Effects of Pennsaid on Clinical Neuropathic Pain Active, not recruiting Massachusetts General Hospital N/A The purpose of this study is to see if the drug Pennsaid (Diclofenac) can help reduce pain felt by people with chronic nerve pain. The drug will be used 2-4 times each day for 2 weeks. The U.S. Food and Drug Administration (FDA) has approved Pennsaid to treat osteoarthritis (bone pain), but the FDA has not approved Pennsaid to treat neuropathic (nerve) pain. The research study will compare Pennsaid to placebo.
NCT01511939 Trial to See if Topical Pennsaid for Knee Pain Affects Coagulation Values in Patients Who Are Also Taking Anticoagulants Completed Arthritis Treatment Center, Maryland Phase 3 The purpose of this study is to see if using a topical nonsteroidal antiinflammatory drug (Pennsaid) to treat osteoarthritis knee pain will affect coagulation values in patients who are also taking anticoagulant or antithrombotic medications.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Pennsaid

Condition Name

Condition Name for Pennsaid
Intervention Trials
Osteoarthritis of the Knee 2
Pain 2
Osteoarthritis of the Hand 1
Neuralgia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Pennsaid
Intervention Trials
Osteoarthritis 3
Osteoarthritis, Knee 2
Emergencies 1
Hemostatic Disorders 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Pennsaid

Trials by Country

Trials by Country for Pennsaid
Location Trials
United States 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Pennsaid
Location Trials
Florida 2
Maryland 1
Massachusetts 1
Utah 1
Virginia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Pennsaid

Clinical Trial Phase

Clinical Trial Phase for Pennsaid
Clinical Trial Phase Trials
Phase 3 1
Phase 2 1
Phase 1 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Pennsaid
Clinical Trial Phase Trials
Completed 3
Approved for marketing 1
Withdrawn 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Pennsaid

Sponsor Name

Sponsor Name for Pennsaid
Sponsor Trials
Mallinckrodt 3
Medtronic - MITG 2
Massachusetts General Hospital 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Pennsaid
Sponsor Trials
Industry 6
Other 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
QuintilesIMS
McKinsey
Cipla
Julphar
Deloitte
Fuji
Chubb
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.